Tuesday, October 03, 2023 6:29:52 PM
Unfortunately the company once again set the stage for this. Everyone picking over the breadcrumbs.
Wouldn’t it have been ripe if they PR’d on day 30 they accomplished their goal. Holy cow that would have been awesome!
Instead we have shorts salivating and pumpers defending. Miss the 45 day mark and it doesn’t really matter that it was an estimate or it was an approximate. They will have missed and that will be reflected in share price, don’t you think? I know in the long term it won’t really matter. Just sucks in the moment. Truthfully I am tired of “buying opportunities”. That just means they missed the mark again. Patients are impacted so I get no joy in that. I am ready for results. Ready for approval. Ready for commercialization and delivery to patients.
When I tell someone at work “I can probably get that to you by Friday”, I make sure it’s in their inbox on Thursday. If it’s not, it’s late.
They gave themselves a window. Hope they make it.
Wouldn’t it have been ripe if they PR’d on day 30 they accomplished their goal. Holy cow that would have been awesome!
Instead we have shorts salivating and pumpers defending. Miss the 45 day mark and it doesn’t really matter that it was an estimate or it was an approximate. They will have missed and that will be reflected in share price, don’t you think? I know in the long term it won’t really matter. Just sucks in the moment. Truthfully I am tired of “buying opportunities”. That just means they missed the mark again. Patients are impacted so I get no joy in that. I am ready for results. Ready for approval. Ready for commercialization and delivery to patients.
When I tell someone at work “I can probably get that to you by Friday”, I make sure it’s in their inbox on Thursday. If it’s not, it’s late.
They gave themselves a window. Hope they make it.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
